VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19Zhujun Cao, Ren Zhao, Shuya Mei et al.|New England Journal of Medicine|2022Cited by 227
Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled studyJiao Liu, Dechang Chen, Xiaojun Pan et al.|The Lancet Regional Health - Western Pacific|2023Cited by 112